Cancer remains one of the most critical global health challenges, increasing dependence on effective drug-based therapies. The global value of anti-cancer drugs was estimated at around USD 185 billion in 2024 and is expected to exceed USD 320 billion by 2032, growing at a compound annual growth rate (CAGR) of approximately 7.2%. Rising cancer incidence, expanding treatment access, and...